Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan L Epstein

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Cancer Research|August 28, 2003
Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosisPeisheng Hu, Jianghua Yan, Jahangir Sharifi, et al.
International Journal of Molecular Sciences|July 2, 2021
Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and PerspectivesAida Kouhi, Vyshnavi Pachipulusu, Talya Kapenstein, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 9, 2008
Soluble Fc fusion proteins for biomedical researchMeg L Flanagan, Robyn S Arias, Peisheng Hu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 24, 2022
Eliciting anti-cancer immunity by genetically engineered multifunctional exosomesQinqin Cheng, Zhefu Dai, Goar Smbatyan, et al.
Cancer Research|November 4, 2010
A therapeutic OX40 agonist dynamically alters dendritic, endothelial, and T cell subsets within the established tumor microenvironmentAngela D Pardee, Dustin McCurry, Sean Alber, et al.
Planta|April 25, 2012
The perichromatin region of the plant cell nucleus is the area with the strongest co-localisation of snRNA and SR proteinsJanusz Niedojadło, Zbigniew Mikulski, Konrad Dełeńko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitroTrevor E Angell, Melissa G Lechner, Julie K Jang, et al.
Biomaterials|September 11, 2020
Adaptable antibody Nanoworms designed for non-Hodgkin lymphomaChangrim Lee, Santosh Peddi, Caleb Anderson, et al.
Biomacromolecules|July 6, 2019
Generation of a Monoclonal Antibody to Detect Elastin-like PolypeptidesAida Kouhi, Zhiyuan Yao, Long Zheng, et al.
European Journal of Immunology|June 1, 2013
Modulation of Treg cells/T effector function by GITR signaling is context-dependentAmal Ephrem, Alan L Epstein, Geoffrey L Stephens, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Cancer Research|August 28, 2003
Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosisPeisheng Hu, Jianghua Yan, Jahangir Sharifi, et al.
International Journal of Molecular Sciences|July 2, 2021
Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and PerspectivesAida Kouhi, Vyshnavi Pachipulusu, Talya Kapenstein, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 9, 2008
Soluble Fc fusion proteins for biomedical researchMeg L Flanagan, Robyn S Arias, Peisheng Hu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 24, 2022
Eliciting anti-cancer immunity by genetically engineered multifunctional exosomesQinqin Cheng, Zhefu Dai, Goar Smbatyan, et al.
Cancer Research|November 4, 2010
A therapeutic OX40 agonist dynamically alters dendritic, endothelial, and T cell subsets within the established tumor microenvironmentAngela D Pardee, Dustin McCurry, Sean Alber, et al.
Planta|April 25, 2012
The perichromatin region of the plant cell nucleus is the area with the strongest co-localisation of snRNA and SR proteinsJanusz Niedojadło, Zbigniew Mikulski, Konrad Dełeńko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitroTrevor E Angell, Melissa G Lechner, Julie K Jang, et al.
Biomaterials|September 11, 2020
Adaptable antibody Nanoworms designed for non-Hodgkin lymphomaChangrim Lee, Santosh Peddi, Caleb Anderson, et al.
Biomacromolecules|July 6, 2019
Generation of a Monoclonal Antibody to Detect Elastin-like PolypeptidesAida Kouhi, Zhiyuan Yao, Long Zheng, et al.
European Journal of Immunology|June 1, 2013
Modulation of Treg cells/T effector function by GITR signaling is context-dependentAmal Ephrem, Alan L Epstein, Geoffrey L Stephens, et al.
Pageof 10